Science Explorer Back to mapMap
Discussion
Topic · Radiology, Nuclear Medicine and Imaging

Retinopathy of Prematurity Studies

Retinopathy of Prematurity Studies is a research topic within Radiology, Nuclear Medicine and Imaging. Science Explorer counts 13k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis, treatment, and risk factors associated with retinopathy of prematurity, a potentially blinding eye disorder that primarily affects premature infants. It covers topics such as screening examinations, use of intravitreal bevacizumab, neurodevelopmental outcomes, and the role of vascular endothelial growth factor and oxygen in the pathogenesis of the condition.

  • Retinopathy
  • Prematurity
  • Treatment
  • Screening
  • Infants
  • Vascular Endothelial Growth Factor
  • Oxygen
  • Telemedicine
  • Intravitreal Bevacizumab
  • Neurodevelopmental Outcomes
Research works
13k
fractional, since 1950
In the world top 10%
1.3k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+11%
the tick is no change
Largest producer
United States
29% of the 10 largest, 2022-now
Retinopathy of Prematurity Studies

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Retinopathy of Prematurity Studies research?

By volume, the United States and China publish the most (593 and 555 works in 2022-now).

By volume, 2022-now

  1. 1 United States 593 works
  2. 2 China 555 works
  3. 3 India 300 works
  4. 4 United Kingdom 136 works
  5. 5 Türkiye 102 works
  6. 6 Japan 87 works
  7. 7 Germany 78 works
  8. 8 Australia 68 works
  9. 9 Italy 61 works
  10. 10 Spain 59 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 29.1%China: 27.2%India: 14.7%United Kingdom: 6.6%6 others listed: 22.3%29%largest
United States593 · 29.1%China555 · 27.2%India300 · 14.7%United Kingdom136 · 6.6%6 others listed456 · 22.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead Retinopathy of Prematurity Studies research?

By volume in 2022-now, Harvard University publishes the most Retinopathy of Prematurity Studies research, followed by Sun Yat-sen University and All India Institute of Medical Sciences.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 37 works
  2. 2 Sun Yat-sen UniversityChina 32 works
  3. 3 All India Institute of Medical SciencesIndia 30 works
  4. 4 Wenzhou Medical UniversityChina 23 works
  5. 5 Capital Medical UniversityChina 22 works
  6. 6 L V Prasad Eye InstituteIndia 20 works
  7. 7 University College LondonUnited Kingdom 19 works
  8. 8 Shanghai Jiao Tong UniversityChina 19 works
  9. 9 Tianjin Medical UniversityChina 18 works
  10. 10 Johns Hopkins UniversityUnited States 16 works

Who are the leading researchers in Retinopathy of Prematurity Studies?

The most-cited researchers publishing on Retinopathy of Prematurity Studies include Theo Vos, Ali H. Mokdad and Julian P. T. Higgins.

  1. 1 Theo Vos United States 439k citations
  2. 2 Ali H. Mokdad United States 429k citations
  3. 3 Julian P. T. Higgins United Kingdom 390k citations
  4. 4 Guido Kroemer France 386k citations
  5. 5 Jost Bruno Jonas Germany 350k citations
  6. 6 Cyrus Cooper United Kingdom 342k citations
  7. 7 Gregory Y.H. Lip United Kingdom 311k citations
  8. 8 Lesley A. Stewart United Kingdom 308k citations
  9. 9 Farshad Farzadfar Iran 298k citations
  10. 10 Naohiro Yonemoto Japan 297k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Retinopathy of Prematurity Studies?

The most cited paper in Retinopathy of Prematurity Studies is "Global estimates of visual impairment: 2010" (Donatella Pascolini, Silvio Paolo Mariotti, 2011), with 3,835 citations. Next come "Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis" (3,541) and "Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study" (3,188).

Most cited papers
#PaperReleasedCitations
1 Global estimates of visual impairment: 2010 Donatella Pascolini, Silvio Paolo Mariotti · British Journal of Ophthalmology Dec 2011 3,835
2 Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis Seth Flaxman et al. · The Lancet Global Health ReviewOpen access117 authors 13 Oct 2017 3,541
3 Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study Jaimie D Steinmetz et al. · The Lancet Global Health Open access243 authors Dec 2020 3,188
4 Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network Barbara J. Stoll et al. · PEDIATRICS Open access 23 Aug 2010 2,772
5 Pegaptanib for Neovascular Age-Related Macular Degeneration Evangelos S. Gragoudas, Anthony P. Adamis, Emmett T. Cunningham et al. · New England Journal of Medicine Open access 29 Dec 2004 2,343
All 100 most cited papers, with filters and sorting

Where is Retinopathy of Prematurity Studies research done?

The largest centres of Retinopathy of Prematurity Studies research in 2022-now are Beijing (China), Guangzhou (China), London (United Kingdom) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Wenzhou and Hyderabad.

Largest cities, 2022-now

  1. 1 BeijingChina 63 works
  2. 2 GuangzhouChina 57 works
  3. 3 LondonUnited Kingdom 54 works
  4. 4 ShanghaiChina 51 works
  5. 5 IstanbulTürkiye 36 works
  6. 6 MoscowRussia 35 works
  7. 7 BostonUnited States 32 works
  8. 8 SeoulSouth Korea 31 works
  9. 9 New DelhiIndia 30 works
  10. 10 TokyoJapan 29 works

Where it is the local speciality

  1. WenzhouCN · 23.0 works8.9×
  2. HyderabadIN · 24.9 works4.4×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Retinopathy of Prematurity Studies than the world average.

See Retinopathy of Prematurity Studies on the map

Where is the best place to study Retinopathy of Prematurity Studies?

Among universities, judged by research, The University of Melbourne, Harvard University and Tianjin Medical University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 18.67%fractional works in this field (log) →share of work in the world top 10% →The University of Me…Tianjin Medical Univ…Sun Yat-sen UniversityHarvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1The University of MelbourneAustralia 67.638.1%4.1×12 +20.9%
2Harvard UniversityUnited States 65.614.1%4.5×37 +1.1%
3Tianjin Medical UniversityChina 62.828.4%18.6×18 +32.1%
4Sun Yat-sen UniversityChina 62.514.5%5.9×32 +33.8%
5Chinese University of Hong KongChina 59.321.0%6.2×12 +97.1%
6Capital Medical UniversityChina 57.018.3%7.9×22 +55.0%
7Wenzhou Medical UniversityChina 56.015.1%17.3×23 +40.3%
8Johns Hopkins UniversityUnited States 54.215.0%4.1×16 +12.9%
9All India Institute of Medical SciencesIndia 52.24.7%10.5×30 +28.6%
10University College LondonUnited Kingdom 51.317.5%4.6×19 -22.4%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Retinopathy of Prematurity Studies, country by country

Is Retinopathy of Prematurity Studies research growing?

Output in 2022-2025 was 11% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Retinopathy of Prematurity Studies.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Retinopathy of Prematurity Studies as a percentage of every work published that year, 0.010% in 2024.

still counting0.0050%0.010%0.015%Retinopathy of Prematurity Studies0.013% in 202519801990200020102020

Fractional works of Retinopathy of Prematurity Studies over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Retinopathy of Prematurity Studies10.1% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Retinopathy of Prematurity Studies. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.